| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/30/2008 | CN100406436C Crystal forms of atorvastatin hemi-calcium and processes for preparing atorvastatin hemi-calcium forms IX |
| 07/30/2008 | CN100406435C 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 07/29/2008 | US7405307 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405297 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2337544C Methods for making optically active 3-aminopyrrolidine-2,5-dione derivative and optically active 3-aminopyrrolidine derivative |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2222936C Pesticidal sulfur compounds |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/24/2008 | WO2008087421A2 Male contraceptive |
| 07/24/2008 | WO2008067417A3 Nitroxides for use in treating or preventing hypercholesterolemia |
| 07/24/2008 | WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 07/24/2008 | WO2007127473A3 Poly (ethylene glycol) containing chemically disparate endgroups |
| 07/24/2008 | US20080177087 Atorvastatin calcium propylene glycol solvates |
| 07/24/2008 | US20080177079 Reacting 2-fluoropropionic acid to 2-fluoropropionyl chloride; reacting with pyrrolidine to form N-(2-fluoropropionyl)pyrrolidine; N-(2-fluoropropionyl)benzoxazolinone; chemical intermediates for 1-(2-deoxy-2-fluoro-2-C-methyl- beta -D-ribofuranosyl)cytosine antihepatitis C virus agents; concentration |
| 07/24/2008 | US20080177016 radiation curable aromatic olefins, acrylic polymers, vinyl esters or vinyl ether polymers, functionalized with chromogens, used for dispersion of inks, capable of producing images of high image quality with a high optical density |
| 07/24/2008 | US20080176925 Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 07/24/2008 | US20080176924 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
| 07/24/2008 | US20080176923 particularly cis-hydroxyproline derivatives; inhibit or prevent proliferation, infiltration, invasion, angiogenesis and/or metastasization of cancer cells; 1-methyl-4-phenylaminocarbonyloxyproline ethyl ester; can be use as hybrid molecules or in combined agents; oral bioavailibility; chemical stability |
| 07/24/2008 | US20080176906 excellent androgen receptor antagonism, excellent pharmacokinetics; low toxicity; anticarcinogenic agents; 1-{[6-Chloro-5-(hydroxymethyl)pyridin-3-yl]methyl}-4-(4-cyanophenyl)-2,5-dimethyl-1H-pyrrole-3-carbonitrile |
| 07/24/2008 | US20080176898 Leukotriene antagonists; cardiovascular disorders like unstable angina pectoris or myocardial infarction; Methyl 1-{[5-(ethoxycarbonyl)-2-(3-{4-[(4-isopropoxybenzyl)oxy]phenyl}propoxy)phenyl]-acetyl}piperidine-4-carboxylate |
| 07/24/2008 | US20080176864 [4-(3-Methoxy-phenyl)-4-oxo-butyl]-carbamic acid tert-butyl ester; Age related functional decline, osteoporosis, osteopenia, bone fractures, male and female sexual dysfunction, erectile dysfunction, depression, prostate cancer, decreased cognitive ability, or lethargy |
| 07/24/2008 | US20080176848 e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders |
| 07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
| 07/24/2008 | US20080176838 e.g. [3-[(Cyclopropanecarbonyl-amino)-methyl]-pyrrolidin-1-yl}-(2-fluoro-benzyl)-propyl]-carbamic acid tert-butyl ester; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes; |
| 07/24/2008 | US20080176763 Collection of Traceable Compounds and Uses Thereof |
| 07/24/2008 | US20080176748 derived from 3-acetyl-4-hydroxy-5-sec-butylpyrroline-2-ketone, a natural substance, and their potential use in agriculture for weed control |
| 07/23/2008 | EP1947084A2 2-Pyrrolidones as intermediates for the preparation of pyrrolidines |
| 07/23/2008 | EP1947083A1 Process for production of aralkyloxypyrrolidine derivative |
| 07/23/2008 | EP1947082A2 Oximes or imines of 4-pentulosonic acid methyl esters as intermediates for the preparation of pyrrolidines |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof |
| 07/23/2008 | EP1945602A1 Hydrogen-catalysed process for preparing (meth)acrylates of n-hydroxyalkylated lactams |
| 07/23/2008 | EP1730109B1 Synthesis of pyrrole-2-carbonitriles |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1567489B1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/23/2008 | EP1389223B1 Method for producing polyisocyanates |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | CN101228121A Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/23/2008 | CN101227901A Anti-inflammatory agents |
| 07/23/2008 | CN101225069A Method for synthesizing meropenem intermediate |
| 07/22/2008 | US7402711 Polymerizing tetrahydrofuran in the presence of a catalyst, an accelerator, and an ionic liquid composed of 5-methyl-2-pyrrlidon-1-ylalkylammonium organosulfonate or organosulfonimide at 0-75 degrees C. and separating the polymer from the ionic liquid that contains the catalyst |
| 07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402684 Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402670 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402262 electropolymerized conductive polymers (ECPs) capable of immobilizing biomolecules and ligands such as enzymes, proteins, antibodies and small ligands such as catalysts, porphyrins, DNA, cDNA and RNA sequences |
| 07/22/2008 | CA2278223C 1,4-dihydropyridin derivatives and their use in therapy |
| 07/17/2008 | WO2008084383A2 Process for preparing vildagliptin |
| 07/17/2008 | WO2008083967A2 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid |
| 07/17/2008 | WO2008083729A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | US20080171886 Preparation Of An Atorvastatin Intermediate Using A Paal-Knorr Condensation |
| 07/17/2008 | US20080171872 Ammonium, hydrate, diethylamine, dibenzylamine, piperazine, morpholine salts of atorvastin; Hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, Alzheimer's Disease |
| 07/17/2008 | US20080171784 Stabilization of the pharmaceutical active solid substance atorvastatin (Lipitor) alone or in a mixture with other solid substances embedded in a surrounding gaseous mixturewhere a partial pressure of oxygen of at < 2 kPa is maintained; amorphous; blister-pack using an oxygen self-activating absorber |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171681 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners |
| 07/17/2008 | CA2674408A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | CA2674291A1 New process |
| 07/16/2008 | EP1944288A1 Radiolabelling via fluorination of aziridines |
| 07/16/2008 | EP1943254A1 Reagents for highly specific detection of peroxynitrite |
| 07/16/2008 | EP1943218A2 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 07/16/2008 | EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 07/16/2008 | EP1943216A1 Prolinamide derivatives as sodium channel modulators |
| 07/16/2008 | EP1943215A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/16/2008 | EP1830840B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2008 | EP1660445A4 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 07/16/2008 | EP1556376B1 Large conductance calcium-activated k channel opener |
| 07/16/2008 | EP1386913B1 Pyrrole derivative |
| 07/16/2008 | CN101223252A Phenylazo-acetoacetanilide derivatives with a polymer! zable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks |
| 07/16/2008 | CN101219984A Amine salt compound of carboxylic acid having thermal dissociation portion and compounding agent for rubber vulcanization and rubber composition containing the same |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia |
| 07/16/2008 | CN100402026C Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 07/15/2008 | US7399870 Reacting a pyrrole with chlorosulfonyl isocyanate in the presence of a solvent and contacting the resulting product with a molar excess of an amide such as N,N-dimethylformamide |
| 07/15/2008 | US7399869 N-blocked peptide proline boronate compounds; hyperproliferative disorders like cancer, neurodegeneration, cardiac hypertrophy, pain, migraine, neurotraumatic disease, cirrhosis, fibromatosis, and rheumatoid arthritis |
| 07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 07/15/2008 | US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399773 Intermediates in the synthesis of atorvastatin calcium (Lipitor (reg)), 5-(4-fluorophenyl)-2-isopropyl-1-(4-(morpholinocarbonylmethylcarbonyl)-2-hydroxybutyl)-4-phenyl-3-(N-phenylcarbamoyl)-1H-pyrrole for example |
| 07/15/2008 | US7399748 Intravenous administration of a alpha -halogen- acryloyl distamycin derivative for therapy of tumors |
| 07/15/2008 | CA2479924C Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 07/15/2008 | CA2465640C Process for forming amorphous atorvastatin |
| 07/15/2008 | CA2392096C Polymorphic form of atorvastatin calcium |
| 07/10/2008 | WO2008082250A1 Improved process for the preparation of non-crystalline atorvastatin calcium |
| 07/10/2008 | WO2008081860A1 Optically active succinic acid imide derivative, process for production thereof, and use thereof |
| 07/10/2008 | WO2008081644A1 PROCESS FOR PRODUCTION OF α-OLEFIN LOW POLYMERS AND METHOD FOR STORAGE OF PYRROLE COMPOUNDS |
| 07/10/2008 | WO2008081017A1 New n-alkynylcarboxamide derivatives |
| 07/10/2008 | WO2008053393A3 Rotary actuator |
| 07/10/2008 | WO2008021796A3 Pyrrolidinone anilines as progesterone receptor modulators |
| 07/10/2008 | US20080167480 Combining an aqueous solution of a substituted ketoalkyloxysodium compound with an oxime compound in presence of zinc, dioxane, water to form a cyclic pyrrole comound with an ester group, acetylating and hydrolyzing the intermediate |
| 07/10/2008 | US20080167479 Process for preparing vildagliptin |
| 07/10/2008 | US20080167474 Effective agents for trapping and indentifying free radical species and find use as efficient antioxidants in physicochemical and biological systems; treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine-mediated conditions |
| 07/10/2008 | US20080167468 Silacycle compounds and methods of use thereof |